Amarin Corp. (AMRN): 2Q26 First Take: Awaiting topline pull through from volume growth

Research evidence excerpt

Amarin Corp. (AMRN): 2Q26 First Take: Awaiting topline pull through from volume growth

to any matters

arising from, or in connection with, this research. Taiwan: This material is for reference only and must not be reprinted without permission. Investors

should carefully consider their own investment risk. Investment results are the responsibility of the individual investor. United Kingdom: Persons who

would be categorized as retail clients in the United Kingdom, as such term is defined in the rules of the Financial Conduct Authority, should read this

research in conjunction with prior Goldman Sachs research on the covered companies referred to herein and should refer to the risk warnings that have

been sent to them by Goldman Sachs International. A copy of these risks warnings, and a glossary of certain financial terms used in this report, are

available from Goldman Sachs International on request.

European Union and United Kingdom: Disclosure information in relation to Article 6 (2) of the European Commission Delegated Regulation (EU)

(2016/958) supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council (including as that Delegated Regulation is

implemented into United Kingdom domestic law and regulation following the United Kingdom’s departure from the European Union and the European

Economic Area) with regard to regulatory technical standards for the technical arrangements for objective presentation of investment

recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of

conflicts of interest is available at https://www.gs.com/disclosures/europeanpolicy.html which states the European Policy for Managing Conflicts of